We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$3.61B
AUM Growth
-$151M
Cap. Flow
-$239M
Cap. Flow %
-6.63%
Top 10 Hldgs %
78.3%
Holding
307
New
3
Increased
130
Reduced
84
Closed
19

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$4.43M
2
UNH icon
UnitedHealth
UNH
+$2.97M
3
LOW icon
Lowe's Companies
LOW
+$2.31M
4
UBER icon
Uber
UBER
+$2.15M
5
META icon
Meta Platforms (Facebook)
META
+$1.95M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$61.2M
2
BSX icon
Boston Scientific
BSX
+$44.9M
3
IT icon
Gartner
IT
+$12.9M
4
AMZN icon
Amazon
AMZN
+$10.5M
5
LLY icon
Eli Lilly
LLY
+$9.63M

Sector Composition

Rank Sector Weight
1 Healthcare 57.96%
2 Technology 8.83%
3 Energy 7.82%
4 Consumer Discretionary 4.91%
5 Utilities 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIO icon
101
Rio Tinto
RIO
$158B
$1.19M 0.03%
20,161
-135
-0.7% -$8.62K
ES icon
102
Eversource Energy
ES
$27.8B
$1.16M 0.03%
20,104
-251
-1% -$15.6K
IWB icon
103
iShares Russell 1000 ETF
IWB
$47.9B
$1.06M 0.03%
3,300
+10
+0.3% +$3.24K
PRME icon
104
Prime Medicine
PRME
$545M
$1.05M 0.03%
361,136
VTI icon
105
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
$1.05M 0.03%
3,617
+22
+0.6% +$6.42K
OTIS icon
106
Otis Worldwide
OTIS
$27.3B
$1.04M 0.03%
11,263
+25
+0.2% +$2.51K
MMM icon
107
3M
MMM
$90.8B
$1.02M 0.03%
7,925
+15
+0.2% +$1.97K
BCE icon
108
BCE
BCE
$20.2B
$1.01M 0.03%
43,427
-1,822
-4% -$52.4K
MAR icon
109
Marriott International
MAR
$99B
$1M 0.03%
3,595
+8
+0.2% +$2.2K
CVS icon
110
CVS Health
CVS
$134B
$964K 0.03%
21,482
-7,328
-25% -$411K
AMGN icon
111
Amgen
AMGN
$209B
$953K 0.03%
3,655
+30
+0.8% +$8.9K
FDX icon
112
FedEx
FDX
$73B
$942K 0.03%
3,349
+17
+0.5% +$4.75K
DHR icon
113
Danaher
DHR
$138B
$850K 0.02%
3,704
-5,193
-58% -$1.28M
PFE icon
114
Pfizer
PFE
$142B
$840K 0.02%
31,678
-1,671
-5% -$45.3K
DOCU
115
DocuSign
DOCU
$10.4B
$814K 0.02%
9,053
NSC icon
116
Norfolk Southern
NSC
$75B
$812K 0.02%
3,461
TSCO icon
117
Tractor Supply
TSCO
$15.8B
$800K 0.02%
15,075
+50
+0.3% +$2.83K
WY icon
118
Weyerhaeuser
WY
$16.9B
$781K 0.02%
27,743
+127
+0.5% +$3.96K
USB icon
119
US Bancorp
USB
$98B
$757K 0.02%
15,819
-19,575
-55% -$963K
APD icon
120
Air Products & Chemicals
APD
$66.8B
$676K 0.02%
2,330
+13
+0.6% +$4.08K
GWW icon
121
W.W. Grainger
GWW
$64B
$674K 0.02%
639
+1
+0.2% +$1.13K
ECL icon
122
Ecolab
ECL
$78.6B
$665K 0.02%
2,836
+6
+0.2% +$1.49K
DVN icon
123
Devon Energy
DVN
$50.9B
$622K 0.02%
19,014
-334
-2% -$12.6K
KR icon
124
Kroger
KR
$35.4B
$611K 0.02%
9,991
+53
+0.5% +$3.11K
MCD icon
125
McDonald's
MCD
$191B
$604K 0.02%
2,084
+12
+0.6% +$3.58K

Similar funds

Bollard Group's Q4 2024 Portfolio in Review

As of Q4 2024, Bollard Group held 307 positions worth $3.61B, down 4% from $3.76B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bollard Group withdrew a net $239M in Q4 2024, closing 19 positions and reducing 84 holdings. Its most notable exit was Fidelity High Dividend ETF, an estimated $7.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 57% a quarter earlier, followed by Technology and Energy.

Against the trend, Bollard Group opened a new position in Celestica worth $65K.

  • Bollard Group's largest Q4 2024 buy was Celestica: 700 shares worth $65K.
  • Bollard Group added most to Visa in Q4 2024, an estimated $4.43M increase.
  • Bollard Group's biggest Q4 2024 reduction was Thermo Fisher Scientific, cutting an estimated $61.2M.
  • Bollard Group fully exited Fidelity High Dividend ETF in Q4 2024, selling an estimated $7.04M.
  • Bollard Group's ten largest holdings make up 78% of its $3.61B portfolio in Q4 2024.
  • Bollard Group opened 3 new positions and closed 19 in Q4 2024.
  • Bollard Group's portfolio value fell 4% quarter-over-quarter to $3.61B.

Based on Bollard Group's 13F filing for Q4 2024, filed 14 Feb 2025.